AR043917A1 - Copolimero, modificadores de proteinas y composiciones farmaceuticas que comprenden dicho copolimero - Google Patents
Copolimero, modificadores de proteinas y composiciones farmaceuticas que comprenden dicho copolimeroInfo
- Publication number
- AR043917A1 AR043917A1 ARP040100985A ARP040100985A AR043917A1 AR 043917 A1 AR043917 A1 AR 043917A1 AR P040100985 A ARP040100985 A AR P040100985A AR P040100985 A ARP040100985 A AR P040100985A AR 043917 A1 AR043917 A1 AR 043917A1
- Authority
- AR
- Argentina
- Prior art keywords
- copolymer
- optionally substituted
- complex
- formula
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F216/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical
- C08F216/12—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical by an ether radical
- C08F216/14—Monomers containing only one unsaturated aliphatic radical
- C08F216/16—Monomers containing no hetero atoms other than the ether oxygen
- C08F216/18—Acyclic compounds
- C08F216/20—Monomers containing three or more carbon atoms in the unsaturated aliphatic radical
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L71/00—Compositions of polyethers obtained by reactions forming an ether link in the main chain; Compositions of derivatives of such polymers
- C08L71/02—Polyalkylene oxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
- C08F222/04—Anhydrides, e.g. cyclic anhydrides
- C08F222/06—Maleic anhydride
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F8/00—Chemical modification by after-treatment
- C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
- C08F8/32—Introducing nitrogen atoms or nitrogen-containing groups by reaction with amines
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F216/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical
- C08F216/12—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical by an ether radical
- C08F216/14—Monomers containing only one unsaturated aliphatic radical
- C08F216/1416—Monomers containing oxygen in addition to the ether oxygen, e.g. allyl glycidyl ether
- C08F216/1425—Monomers containing side chains of polyether groups
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Se provee un copolímero o una sal farmacológicamente aceptable del mismo que contiene, como unidades constituyentes, a) una o más unidades estructurales de fórmula (1), en donde m es un entero de 3 a 100, Alk representa un grupo alquileno, y R1 y R2 son iguales o diferentes, y cada uno representa hidrógeno o alquilo sustituido opcionalmente, y b) una o más unidades estructurales de fórmula (2), en donde R3 representa hidroxilo, alcoxi sustituido opcionalmente, ariloxi sustituido opcionalmente, o un grupo representado por la fórmula: -NR4R5, en donde R4 y R5 son iguales o diferentes entre sí, y cada uno representa hidrógeno o alquilo sustituido opcionalmente; se provee además una composición farmacéutica que comprende dicho copolímero, un modificador de proteínas que comprende dicho copolímero, un complejo de dicho copolímero con una proteína, un método para prevenir o tratar enfermedades usando dicho complejo, el uso de dicho complejo en la fabricación de un medicamento para prevenir o tratar enfermedades, y métodos para la síntesis de dichos copolímeros y dichos complejos.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003080389 | 2003-03-24 | ||
JP2003355853 | 2003-10-16 | ||
JP2003426598 | 2003-12-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR043917A1 true AR043917A1 (es) | 2005-08-17 |
Family
ID=33101948
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040100985A AR043917A1 (es) | 2003-03-24 | 2004-03-24 | Copolimero, modificadores de proteinas y composiciones farmaceuticas que comprenden dicho copolimero |
Country Status (23)
Country | Link |
---|---|
US (1) | US7811556B2 (es) |
EP (1) | EP1611173B1 (es) |
KR (1) | KR20050118201A (es) |
AR (1) | AR043917A1 (es) |
AT (1) | ATE388173T1 (es) |
AU (1) | AU2004223964B2 (es) |
BR (1) | BRPI0408526A (es) |
CA (1) | CA2520450C (es) |
CL (1) | CL2004000633A1 (es) |
DE (1) | DE602004012241T2 (es) |
DK (1) | DK1611173T3 (es) |
ES (1) | ES2301978T3 (es) |
HK (1) | HK1078598A1 (es) |
IL (1) | IL170489A (es) |
MX (1) | MXPA05010289A (es) |
NZ (1) | NZ542352A (es) |
PA (1) | PA8598701A1 (es) |
PE (1) | PE20041067A1 (es) |
PL (1) | PL1611173T3 (es) |
PT (1) | PT1611173E (es) |
SI (1) | SI1611173T1 (es) |
TW (1) | TWI293882B (es) |
WO (1) | WO2004085500A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2090599A1 (de) * | 2008-02-13 | 2009-08-19 | Construction Research and Technology GmbH | Copolymer mit Polyetherseitenketten und Dicarbonsäurederivatbausteinen |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1217005A (en) * | 1916-05-08 | 1917-02-20 | Judson D Mccarthy | Photographic-printing frame. |
DE3260845D1 (en) * | 1981-01-16 | 1984-11-08 | Nippon Catalytic Chem Ind | Copolymer and method for manufacture thereof |
JP2701295B2 (ja) | 1987-03-13 | 1998-01-21 | 日本油脂株式会社 | アリルエーテル−無水マレイン酸共重合体 |
JP2621308B2 (ja) | 1987-03-13 | 1997-06-18 | 日本油脂株式会社 | アリルエーテル−無水マレイン酸共重合体 |
JP2803265B2 (ja) | 1989-12-26 | 1998-09-24 | 日本油脂株式会社 | 変性ポリペプチドおよびその用途 |
US5158622A (en) * | 1991-02-12 | 1992-10-27 | Betz Laboratories, Inc. | Method and composition for treatment of aluminum |
JP3271265B2 (ja) * | 1991-03-07 | 2002-04-02 | 日本油脂株式会社 | 修飾プロテアーゼ |
JP3035675B2 (ja) * | 1991-08-21 | 2000-04-24 | 株式会社コーセー | 修飾スーパーオキシドディスムターゼ |
CA2080174A1 (en) * | 1991-10-11 | 1993-04-12 | John E. Hayes | Polymer polyol dispersants from polymers containing anhydride groups |
JP3106265B2 (ja) | 1992-05-26 | 2000-11-06 | 株式会社コーセー | 修飾リゾチーム |
US6004583A (en) * | 1995-03-22 | 1999-12-21 | Orex Pharmaceutical Development Corp. | Protein-containing polymer composition for oral administration |
US6369027B1 (en) | 1995-12-22 | 2002-04-09 | Amgen Inc. | Osteoprotegerin |
IT1293087B1 (it) | 1997-07-10 | 1999-02-11 | Isi Ist Sierovaccinogeno Ital | Microparticelle a base di materiali polimerici ibridi per il rilascio controllato di molecole biologicamente attive, procedimento per la |
DE19834173A1 (de) * | 1997-08-01 | 1999-02-04 | Sueddeutsche Kalkstickstoff | Copolymere auf Basis von ungesättigten Dicarbonsäure-Derivaten und Oxyalkylenglykol-Alkenylethern |
JPH11302199A (ja) | 1998-04-16 | 1999-11-02 | Sankyo Co Ltd | 薬物運搬体を構成するグラフト共重合体 |
DE19847868C2 (de) * | 1998-10-16 | 2003-09-25 | Clariant Gmbh | Sprengstoffe, enthaltend modifizierte Copolymere aus Polyisobutylen und Maleinsäureanhydrid als Emulgatoren |
JP2002534363A (ja) * | 1999-01-08 | 2002-10-15 | エミスフェアー・テクノロジーズ・インク | ポリマー性デリバリー剤及びデリバリー剤化合物 |
ITTO20000942A1 (it) | 2000-10-10 | 2001-01-10 | Sergio Guzzoni | Pricedimento per la gestione di interscambi di messaggi tra fornitorie clienti di servizi di telefonia. |
JP2003105040A (ja) | 2001-09-28 | 2003-04-09 | Nof Corp | 共重合体の製造方法およびその用途 |
JP5109218B2 (ja) | 2001-09-28 | 2012-12-26 | 日油株式会社 | 共重合体の製造方法 |
-
2004
- 2004-03-23 TW TW093107766A patent/TWI293882B/zh not_active IP Right Cessation
- 2004-03-24 MX MXPA05010289A patent/MXPA05010289A/es active IP Right Grant
- 2004-03-24 PL PL04723056T patent/PL1611173T3/pl unknown
- 2004-03-24 WO PCT/JP2004/004134 patent/WO2004085500A1/en active IP Right Grant
- 2004-03-24 EP EP04723056A patent/EP1611173B1/en not_active Expired - Lifetime
- 2004-03-24 PT PT04723056T patent/PT1611173E/pt unknown
- 2004-03-24 PA PA20048598701A patent/PA8598701A1/es unknown
- 2004-03-24 AR ARP040100985A patent/AR043917A1/es unknown
- 2004-03-24 DE DE602004012241T patent/DE602004012241T2/de not_active Expired - Lifetime
- 2004-03-24 CL CL200400633A patent/CL2004000633A1/es unknown
- 2004-03-24 AT AT04723056T patent/ATE388173T1/de not_active IP Right Cessation
- 2004-03-24 KR KR1020057017757A patent/KR20050118201A/ko not_active Application Discontinuation
- 2004-03-24 NZ NZ542352A patent/NZ542352A/en unknown
- 2004-03-24 ES ES04723056T patent/ES2301978T3/es not_active Expired - Lifetime
- 2004-03-24 PE PE2004000304A patent/PE20041067A1/es not_active Application Discontinuation
- 2004-03-24 SI SI200430653T patent/SI1611173T1/sl unknown
- 2004-03-24 AU AU2004223964A patent/AU2004223964B2/en not_active Ceased
- 2004-03-24 DK DK04723056T patent/DK1611173T3/da active
- 2004-03-24 BR BRPI0408526-4A patent/BRPI0408526A/pt not_active IP Right Cessation
- 2004-03-24 CA CA002520450A patent/CA2520450C/en not_active Expired - Fee Related
-
2005
- 2005-08-25 IL IL170489A patent/IL170489A/en not_active IP Right Cessation
- 2005-09-22 US US11/231,963 patent/US7811556B2/en not_active Expired - Fee Related
-
2006
- 2006-01-09 HK HK06100345A patent/HK1078598A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU2004223964A1 (en) | 2004-10-07 |
AU2004223964B2 (en) | 2007-02-22 |
TW200501986A (en) | 2005-01-16 |
EP1611173B1 (en) | 2008-03-05 |
HK1078598A1 (en) | 2006-03-17 |
PA8598701A1 (es) | 2005-02-04 |
DE602004012241T2 (de) | 2009-03-12 |
WO2004085500A1 (en) | 2004-10-07 |
ES2301978T3 (es) | 2008-07-01 |
PE20041067A1 (es) | 2005-01-22 |
KR20050118201A (ko) | 2005-12-15 |
PT1611173E (pt) | 2008-05-23 |
ATE388173T1 (de) | 2008-03-15 |
CL2004000633A1 (es) | 2005-01-21 |
NZ542352A (en) | 2007-02-23 |
MXPA05010289A (es) | 2005-11-17 |
CA2520450A1 (en) | 2004-10-07 |
DK1611173T3 (da) | 2008-06-23 |
BRPI0408526A (pt) | 2006-03-07 |
CA2520450C (en) | 2009-11-03 |
US20060062754A1 (en) | 2006-03-23 |
IL170489A (en) | 2009-06-15 |
TWI293882B (en) | 2008-03-01 |
EP1611173A1 (en) | 2006-01-04 |
SI1611173T1 (sl) | 2008-08-31 |
US7811556B2 (en) | 2010-10-12 |
PL1611173T3 (pl) | 2008-08-29 |
DE602004012241D1 (de) | 2008-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200621262A (en) | New dihydropteridione derivatives, process for their manufacture and their use as medicament | |
CL2004000917A1 (es) | Compuestos derivados de tiazol; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de enfermedades mediadas por 3-cinasa de dosfatidilnositol tal como enfermedades respiratorias, alergias, artritis reumatoide, osteoa | |
UY28936A1 (es) | Grupo de compuestos benzoil-amino-heterociclilo y composiciones farmaceuticas que los comprenden, utiles para tratamiento de enfermedades mediadas por glucoquinasa (gq) | |
CO5580815A2 (es) | Derivados de adamantana, procesos para su preparacion y composiciones farmaceuticas que los contienen | |
CR9459A (es) | Derivados benzodioxano y benzodioxolano y usos de los mismos | |
GEP20094676B (en) | Piperidine compounds and pharmaceutical compositions containing them | |
TW200738658A (en) | Novel compounds | |
SE0401762D0 (sv) | Novel compounds | |
AR049464A1 (es) | Antagonistas de receptores de acetilcolina muscarinicos. composiciones farmaceuticas | |
UY29234A1 (es) | Derivados de adamantano, composiciones farmacéuticas que los contienen, procedimientos de preparación de ambos y aplicaciones. | |
AR049405A1 (es) | Compuesto de dicetopiperazina, composicion farmaceutica que lo comprende, uso del compuesto para la fabricacion de un medicamento y procedimiento para la preparacion del mismo | |
BR112014023384A2 (pt) | inibidores de bace de di-hidro-tiazina e di-hidro-oxazina espirocíclicos, e composições e usos dos mesmos | |
AR015312A1 (es) | Compuestos inhibidores no peptidilicos de la union a las celulas dependientes de vla-4 utiles en el tratamiento de enfermedades inflamatorias, autoinmunesy respiratorias, composicion farmaceutica y uso de los compuestos en la preparacion de medicamentos | |
AR060690A1 (es) | Polimeros que contienen magnesio para la hiperfosfatemia | |
NO20054340L (no) | Nye sammenkoplede heterocykler og deres anvendelse | |
TW200740781A (en) | Novel compounds | |
SE0403171D0 (sv) | New compounds | |
CL2003002565A1 (es) | Compuestos derivados de 3h-quinazolin-4-ona, su proceso de preparacion, composicion farmaceutica que los contiene, y uso en el tratamiento y prevencion de enfermedades mediadas por inhibidores de mao-b, tales como la enfermedad de alzheimer y demenci | |
SE0302139D0 (sv) | Novel compounds | |
SE0303541D0 (sv) | New compounds | |
BRPI0310032B8 (pt) | derivados de benzoxazina, seus usos e seus processos de produção, e composição farmacêutica | |
UY29892A1 (es) | Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones | |
PE20070830A1 (es) | Composiciones que comprenden una combinacion de antagonistas ccr5 y de cxcr4 | |
AR041786A1 (es) | Derivados de azetidina como antagonistas del receptor ccr-3, un proceso para su preparacion, una composicion farmaceutica y el uso de dichos derivados para la elaboracion de un medicamento | |
CO5611194A2 (es) | Inhibidores novedosos de la farnesil proteina transferasa como agentes antitumorales |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |